Production (Stage)
Bayer Aktiengesellschaft
BAYZF
$27.50
$0.3621.33%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 49.91B | 50.40B | 50.67B | 50.96B | 50.99B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.91B | 50.40B | 50.67B | 50.96B | 50.99B |
| Cost of Revenue | 21.77B | 21.78B | 21.64B | 21.28B | 21.08B |
| Gross Profit | 28.15B | 28.62B | 29.02B | 29.68B | 29.91B |
| SG&A Expenses | 15.90B | 16.15B | 15.96B | 15.79B | 15.58B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 614.78M | -89.65M | -3.76B | -3.15B | -3.21B |
| Total Operating Expenses | 44.55B | 44.13B | 40.33B | 40.33B | 39.78B |
| Operating Income | 5.36B | 6.27B | 10.34B | 10.63B | 11.21B |
| Income Before Tax | -3.47B | -2.58B | -300.75M | -198.71M | -1.81B |
| Income Tax Expenses | 145.82M | 231.69M | 719.91M | 1.19B | 1.61B |
| Earnings from Continuing Operations | -3.62K | -2.82K | -1.02K | -1.39K | -3.42K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.24M | -6.15M | -4.07M | -7.46M | 3.33M |
| Net Income | -3.63B | -2.82B | -1.02B | -1.40B | -3.42B |
| EBIT | 5.36B | 6.27B | 10.34B | 10.63B | 11.21B |
| EBITDA | 9.68B | 10.56B | 14.79B | 15.04B | 15.59B |
| EPS Basic | -3.69 | -2.87 | -1.04 | -1.42 | -3.48 |
| Normalized Basic EPS | 1.87 | 2.45 | 5.07 | 5.13 | 5.51 |
| EPS Diluted | -3.70 | -2.87 | -1.05 | -1.42 | -3.48 |
| Normalized Diluted EPS | 1.87 | 2.45 | 5.07 | 5.13 | 5.51 |
| Average Basic Shares Outstanding | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B |
| Average Diluted Shares Outstanding | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | -3.74% | -4.81% | -13.46% | -9.77% | -75.73% |